Skip to content

Faculty profile

Wafa Hassan

Back to faculty
Research FellowMedicineMcMaster University

Research

Research areas, by share of publications

Research areas are derived from OpenAlex topics of their publications.

34 publications.

01

Mepolizumab for the treatment of refractory chronic cough in patients with eosinophilic airways disease (MUCOSA): a randomised, double-blind, parallel-group, placebo-controlled trial

Diab N, Brister D, Kum E, Wahab M, Hassan W, Beaudin S, Obminski C, Wattie J, Wiltshire L, Howie K

European Respiratory Journal20265 citations
DOI: 10.1183/13993003.01573-2025
02

Prospective study to evaluate the effectiveness of guideline-based therapy for chronic cough and refractory chronic cough: PROCOUGH

Wahab M, Kum E, Diab N, Brister D, Oliveira A, Hassan W, Beaudin S, Stevens C, Wattie J, Wiltshire L

ERJ Open Research20263 citations
DOI: 10.1183/23120541.00279-2026
03

Asthma diagnosis in adults and children: challenges, future directions, and a call to action

Hassan W, Wang R, Mohammedalhadi A, Badri H, Daines L, Aaron SD, Gaillard EA, Fowler SJ, Satia I

The Lancet Respiratory Medicine20263 citationsFirst author
DOI: 10.1016/s2213-2600(26)00143-8
04

Moving Beyond Responders: A post-hoc Analysis Identifying Criteria for Chronic Cough Control

Wahab M, Kum E, Diab N, Brister D, Oliveira A, Hassan W, Beaudin S, Stevens C, Wattie J, Wiltshire L

Chest20262 citations
DOI: 10.1016/j.chest.2026.05.006
05

Recent updates on thymic stromal lymphopoietin as a therapeutic target for asthma

Hansi RK, Whetstone CE, Ranjbar M, Hassan W, Gauvreau GM

Expert Review of Respiratory Medicine20261 citations
DOI: 10.1080/17476348.2026.2615193
06

Reply to: Is the role of eosinophils in refractory chronic cough truly dismissed? Mepolizumab reduced blood and sputum eosinophils, but not eosinophil-derived neurotoxin

Whetstone C, Diab N, Brister D, Kum E, Wahab M, Hassan W, Beaudin S, Obminski C, Wattie J, Wiltshire L

European Respiratory Journal2026
DOI: 10.1183/13993003.00143-2026
07

Associations of secondary spontaneous pneumothorax characteristics with key clinical outcomes – a prospective cohort study

Barton EC, Warren FC, Zheng S, Symonds J, Tucker E, Jackson K, Pearce C, Fahy M, Tan PC, Hassan W

ERJ Open Research2026Senior author
DOI: 10.1183/23120541.00624-2026
08

ATP cough challenge as a novel diagnostic tool to assess cough hypersensitivity syndrome

Kum E, Mohammedalhadi A, Hassan W, Singer R, Beaudin S, Howie K, Stevens C, O'Byrne P, Satia I

Cough2026
DOI: 10.1183/23120541.cc-2026.tp110
09

ATP cough challenge as a novel diagnostic tool to assess cough hypersensitivity

Kum E, Mohammedalhadi A, Hassan W, Singer R, Stevens C, Howie K, Beaudin S, O'Byrne P, Satia I

2026
DOI: 10.15173/mumj.v22i2.4170
10

FeNO as a Treatable Trait in Chronic Cough: Insights from the PROCOUGH Study

Wahab M, Kum E, Diab N, Brister D, Oliveira A, Hassan W, Beaudin S, Stevens C, Wattie J, Wiltshire L

Lung2026
DOI: 10.1007/s00408-026-00913-y
Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for
Subject: Prospective PhD student: Asthma and respiratory diseases Dear Professor Hassan, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Mepolizumab for the treatment of refractory chronic cough in patients with eosinophilic airways disease (MUCOSA): a randomised, double-blind, parallel-group, placebo-controlled trial" (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]
Open in email

Profile data last refreshed on September 25, 2026 from the university directory, OpenAlex and CIHR.

Something wrong or missing on this profile? Suggest a correction